Lower Limb Spasticity Epidemiology Forecast 2025-2034

Increased muscle rigidity, involuntary spasms, and resistance to leg movement are the common conditions of lower limb spasticity. It happens as a result of neurological conditions like multiple sclerosis, stroke, cerebral palsy, spinal cord injury, or traumatic brain injury. Research studies suggest that lower limb spasticity is expected to affect up to 30%-40% of stroke survivors.

Lower Limb Spasticity Epidemiology Forecast Report Coverage

The “Lower Limb Spasticity Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of lower limb spasticity. It projects the future incidence and prevalence rates of lower limb spasticity across various populations. The study covers age and type as major determinants of the lower limb spasticity-affected population. The report highlights patterns in the prevalence of lower limb spasticity over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of lower limb spasticity in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Lower Limb Spasticity: Disease Overview

Lower limb spasticity is a neurological condition characterized by increased muscle tone, stiffness, and involuntary spasms in the legs, leading to impaired movement and pain. It arises from damage to upper motor neurons that may be brought on by diseases such as multiple sclerosis, stroke, cerebral palsy, or spinal cord injury. The disorder impairs posture, balance, and coordination, which frequently restricts movement and day-to-day activities. Over time, spasticity can deteriorate, resulting in joint abnormalities and a lower standard of living. Symptoms include tight muscles, contractures, and trouble walking.

Lower Limb Spasticity: Treatment Overview

Treatment for lower limb spasticity aims to reduce muscle stiffness, improve mobility, and enhance quality of life. Physical therapy helps preserve flexibility and avoid contractures. Drugs like diazepam, tizanidine, and baclofen reduce spasms and muscle tone. Injections of botulinum toxin relax specific muscles, whereas braces and other orthotic devices help with movement and posture. In extreme situations, tendon-lengthening operations or selective dorsal rhizotomy may be considered as surgical options. A multidisciplinary strategy guarantees the best possible management catered to each person's requirements.

Epidemiology

The lower limb spasticity epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for lower limb spasticity by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for lower limb spasticity and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• According to the American Academy of Physical Medicine and Rehabilitation, spasticity affects approximately 35% of people who have had a stroke, 50% of people with traumatic brain injury, 40% of patients with spinal cord injury, more than 90% of people with cerebral palsy, and 37-78% of people with multiple sclerosis. (Matsubara et al.)
• According to a study published in the Journal of Medical Research and Innovation, the prevalence of lower limb spasticity in patients with Parkinson’s disease and corticobasal degeneration was 22.2% and 50%, respectively.
• According to the National Institute for Health and Care Excellence, in England, approximately 110,000 people have a stroke each year and between 19-38% of them (up to 41,800 people) are affected by spasticity.

Country-wise Lower Limb Spasticity Epidemiology

The lower limb spasticity epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of lower limb spasticity varies by country and is influenced by the prevalence of neurological disorders such as stroke, cerebral palsy, multiple sclerosis, spinal cord injury, and traumatic brain injury. Studies suggest that of people who have had a stroke in the United States, 25-43% develop spasticity in their first post-stroke year.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification of lower limb spasticity based on several factors.
• Lower Limb Spasticity Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of lower limb spasticity are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of lower limb spasticity epidemiology in the 8 major markets?
• What will be the total number of patients with lower limb spasticity across the 8 major markets during the forecast period?
• What was the country-wise prevalence of lower limb spasticity in the 8 major markets in the historical period?
• Which country will have the highest number of lower limb spasticity patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of lower limb spasticity during the forecast period of 2025-2034?
• What are the currently available treatments for lower limb spasticity?
• What are the disease risks, signs, symptoms, and unmet needs of lower limb spasticity?

This product will be delivered within 3-5 business days.